The global gene amplification technologies market value was US$ 26.25 billion in 2020. The global gene amplification technologies market value is forecast to reach US$ 35.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 3% during the forecast period from 2021-2030.
Gene amplification is one of the most important techniques used in genomic research, and it plays a crucial role in several other applications, including diagnostics. There are many gene- and signal-amplification mechanisms, such as polymerase chain reaction, ligase chain reaction, transcription-mediated amplification, and dendritic polymers. Research and clinical settings utilize these technologies widely.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic has positively impacted the global gene amplification technologies market. Several COVID-19 diagnostic tests are continuously developed based on different gene amplification methods. In addition, the availability of many new products and technological advances has enhanced the ability to diagnose COVID-19 in the POC setting in an accurate and quick manner. Additionally, PCR is generating significant revenue through its use in the large-scale detection of COVID-19.
Regional Insights
In 2020, North America held dominance in the global market, with the highest revenue share. Among the key factors contributing to the growth of the North America market include research and a commercial base for gene multiplication products and active genetic research programs in the region. Many companies providing gene amplification solutions (instruments, kits, and reagents) have their headquarters in the U.S. This factor has also contributed to the region's high revenue generation.
The Asia Pacific region is forecast to grow the fastest during the forecast period due to government initiatives to develop healthcare infrastructure. In emerging economies, such as China and India, both genomics and molecular diagnostics research and the availability of skilled labor have augmented market growth. For example, Chinese researchers developed a rapid and ultrasensitive ELISA test in April 2021 that incorporated rolling circle amplification for the early diagnosis of various diseases.
Leading Competitors
The leading prominent companies profiled in the global gene amplification technologies market are:
Scope of the Report
The global gene amplification technologies market segmentation focuses on Technology, Downstream, Sample Type, Product, End-use, and Region.
Segmentation based on Technology
Segmentation based on Downstream
Segmentation based on Sample Type
Segmentation based on Product
Segmentation based on End-use
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY TECHNOLOGY
5.1 OVERVIEW
5.2 PCR-BASED AMPLIFICATION
5.3 LOOP-MEDIATED ISOTHERMAL AMPLIFICATION
5.4 NUCLEIC ACID SEQUENCE BASED AMPLIFICATION
5.5 STRAND DISPLACEMENT AMPLIFICATION
5.6 MULTIPLE DISPLACEMENT AMPLIFICATION
5.7 ROLLING CIRCLE AMPLIFICATION
5.8 RAMIFICATION AMPLIFICATION
5.9 OTHERS
6 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY DOWNSTREAM
6.1 OVERVIEW
6.2 WHOLE GENOME AMPLIFICATION
6.3 EXOME SEQUENCING
6.4 SNP GENOTYPING ARRAYS
6.5 ARRAY CGH
6.6 HYBRIDIZATION
6.7 OTHERS
7 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY SAMPLE TYPE
7.1 OVERVIEW
7.2 SINGLE CELL
7.3 FFPE
7.4 OTHERS
8 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 INSTRUMENTS
8.3 KITS & REAGENTS
8.4 SERVICES
9 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY END-USE
9.1 OVERVIEW
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3 ACADEMIC & RESEARCH INSTITUTES
9.4 OTHERS
10 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET, BY GEOGRAPHY
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA MARKET SNAPSHOT
10.2.2 U.S.
10.2.3 CANADA
10.2.4 MEXICO
10.3 EUROPE
10.3.1 EUROPE MARKET SNAPSHOT
10.3.2 WESTERN EUROPE
10.3.2.1 THE UK
10.3.2.2 GERMANY
10.3.2.3 FRANCE
10.3.2.4 ITALY
10.3.2.5 SPAIN
10.3.2.6 REST OF WESTERN EUROPE
10.3.3 EASTERN EUROPE
10.3.3. 1 POLAND
10.3.3.2 RUSSIA
10.3.3.3 REST OF EASTERN EUROPE
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC MARKET SNAPSHOT
10.4.2 CHINA
10.4.3 JAPAN
10.4.4 INDIA
10.4.5 AUSTRALIA & NEW ZEALAND
10.4.6 ASEAN
10.4.7 REST OF ASIA PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
10.5.2 UAE
10.5.3 SAUDI ARABIA
10.5.4 SOUTH AFRICA
10.5.5 REST OF MEA
10.6 SOUTH AMERICA
10.6.1 SOUTH AMERICA MARKET SNAPSHOT
10.6.2 BRAZIL
10.6.3 ARGENTINA
10.6.4 REST OF SOUTH AMERICA
11 GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPANY MARKET RANKING
11.3 KEY DEVELOPMENT STRATEGIES
12 COMPANY PROFILES
12.1 4BASEBIO AG
12.1.1 OVERVIEW
12.1.2 FINANCIAL PERFORMANCE
12.1.3 PRODUCT OUTLOOK
12.1.4 KEY DEVELOPMENTS
12.2 BIO-RAD LABORATORIES
12.2.1 OVERVIEW
12.2.2 FINANCIAL PERFORMANCE
12.2.3 PRODUCT OUTLOOK
12.2.4 KEY DEVELOPMENTS
12.3 DANAHER CORPORATION
12.3.1 OVERVIEW
12.3.2 FINANCIAL PERFORMANCE
12.3.3 PRODUCT OUTLOOK
12.3.4 KEY DEVELOPMENTS
12.4 ILLUMINA INC.
12.4.1 OVERVIEW
12.4.2 FINANCIAL PERFORMANCE
12.4.3 PRODUCT OUTLOOK
12.4.4 KEY DEVELOPMENTS
12.5 LGC GROUP
12.5.1 OVERVIEW
12.5.2 FINANCIAL PERFORMANCE
12.5.3 PRODUCT OUTLOOK
12.5.4 KEY DEVELOPMENTS
12.6 MERCK KGAA
12.6.1 OVERVIEW
12.6.2 FINANCIAL PERFORMANCE
12.6.3 PRODUCT OUTLOOK
12.6.4 KEY DEVELOPMENTS
12.7 MYBIOSOURCE
12.7.1 OVERVIEW
12.7.2 FINANCIAL PERFORMANCE
12.7.3 PRODUCT OUTLOOK
12.7.4 KEY DEVELOPMENTS
12.8. NEW ENGLAND BIOLABS
12.8.1 OVERVIEW
12.8.2 FINANCIAL PERFORMANCE
12.8.3 PRODUCT OUTLOOK
12.8.4 KEY DEVELOPMENTS
12.9 PROMEGA CORPORATION
12.9.1 OVERVIEW
12.9.2 FINANCIAL PERFORMANCE
12.9.3 PRODUCT OUTLOOK
12.9.4 KEY DEVELOPMENTS
12.10 QIAGEN
12.10.1 OVERVIEW
12.10.2 FINANCIAL PERFORMANCE
12.10.3 PRODUCT OUTLOOK
12.10.4 KEY DEVELOPMENTS
12.11 SILICON BIOSYSTEMS
12.11.1 OVERVIEW
12.11.2 FINANCIAL PERFORMANCE
12.11.3 PRODUCT OUTLOOK
12.11.4 KEY DEVELOPMENTS
12.12 TAKARA BIO INC.
12.12.1 OVERVIEW
12.12.2 FINANCIAL PERFORMANCE
12.12.3 PRODUCT OUTLOOK
12.12.4 KEY DEVELOPMENTS
12.13 VAZYME BIOTECH CO. LTD.
12.13.1 OVERVIEW
12.13.2 FINANCIAL PERFORMANCE
12.13.3 PRODUCT OUTLOOK
12.13.4 KEY DEVELOPMENTS
12.14 YIKANG GENE
12.14.1 OVERVIEW
12.14.2 FINANCIAL PERFORMANCE
12.14.3 PRODUCT OUTLOOK
12.14.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved